Literature DB >> 21389279

p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle.

Sarah M Senf1, Pooja B Sandesara, Sarah A Reed, Andrew R Judge.   

Abstract

The Forkhead Box O (FOXO) transcription factors regulate diverse cellular processes, and in skeletal muscle are both necessary and sufficient for muscle atrophy. Although the regulation of FOXO by Akt is well evidenced in skeletal muscle, the current study demonstrates that FOXO is also regulated in muscle via the histone acetyltransferase (HAT) activities of p300/CREB-binding protein (CBP). Transfection of rat soleus muscle with a dominant-negative p300, which lacks HAT activity and inhibits endogenous p300 HAT activity, increased FOXO reporter activity and induced transcription from the promoter of a bona fide FOXO target gene, atrogin-1. Conversely, increased HAT activity via transfection of either wild-type (WT) p300 or WT CBP repressed FOXO activation in vivo in response to muscle disuse, and in C2C12 cells in response to dexamethasone and acute starvation. Importantly, manipulation of HAT activity differentially regulated the expression of various FOXO target genes. Cotransfection of FOXO1, FOXO3a, or FOXO4 with the p300 constructs further identified p300 HAT activity to also differentially regulate the activity of the FOXO homologues. Markedly, decreased HAT activity strongly increased FOXO3a transcriptional activity, while increased HAT activity repressed FOXO3a activity and prevented its nuclear localization in response to nutrient deprivation. In contrast, p300 increased FOXO1 nuclear localization. In summary, this study provides the first evidence to support the acetyltransferase activities of p300/CBP in regulating FOXO signaling in skeletal muscle and suggests that acetylation may be an important mechanism to differentially regulate the FOXO homologues and dictate which FOXO target genes are activated in response to varying atrophic stimuli.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389279      PMCID: PMC3118617          DOI: 10.1152/ajpcell.00255.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  58 in total

Review 1.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

2.  Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization.

Authors:  Li Qiang; Alexander S Banks; Domenico Accili
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

3.  Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy.

Authors:  S A Reed; S M Senf; E W Cornwell; S C Kandarian; A R Judge
Journal:  Biochem Biophys Res Commun       Date:  2011-01-21       Impact factor: 3.575

4.  Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes.

Authors:  Nirmala Hariharan; Yasuhiro Maejima; Jun Nakae; Jihye Paik; Ronald A Depinho; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-10-14       Impact factor: 17.367

5.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

6.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

7.  Coexpression after electroporation of plasmid mixtures into muscle in vivo.

Authors:  Z A Rana; M Ekmark; K Gundersen
Journal:  Acta Physiol Scand       Date:  2004-06

8.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

9.  FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).

Authors:  Armando van der Horst; Leon G J Tertoolen; Lydia M M de Vries-Smits; Roy A Frye; René H Medema; Boudewijn M T Burgering
Journal:  J Biol Chem       Date:  2004-05-04       Impact factor: 5.157

10.  Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase.

Authors:  Seoung Woo Lee; Guoli Dai; Zhaoyong Hu; Xiaonan Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

View more
  42 in total

Review 1.  Regulation of transcription factor activity by interconnected post-translational modifications.

Authors:  Theresa M Filtz; Walter K Vogel; Mark Leid
Journal:  Trends Pharmacol Sci       Date:  2013-12-30       Impact factor: 14.819

Review 2.  FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis.

Authors:  Anthony M J Sanchez; Robin B Candau; Henri Bernardi
Journal:  Cell Mol Life Sci       Date:  2014-05       Impact factor: 9.261

3.  Foxo1 nucleo-cytoplasmic distribution and unidirectional nuclear influx are the same in nuclei in a single skeletal muscle fiber but vary between fibers.

Authors:  Yewei Liu; Sarah J Russell; Martin F Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-29       Impact factor: 4.249

Review 4.  Disuse-induced muscle wasting.

Authors:  Sue C Bodine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-22       Impact factor: 5.085

5.  Muscle Wasting in Fasting Requires Activation of NF-κB and Inhibition of AKT/Mechanistic Target of Rapamycin (mTOR) by the Protein Acetylase, GCN5.

Authors:  Donghoon Lee; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

Review 6.  Acetylation and deacetylation--novel factors in muscle wasting.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Per-Olof Hasselgren
Journal:  Metabolism       Date:  2012-05-22       Impact factor: 8.694

Review 7.  FoxO3a and disease progression.

Authors:  Richard Seonghun Nho; Polla Hergert
Journal:  World J Biol Chem       Date:  2014-08-26

8.  Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

Authors:  Yu-Chou Tseng; Samuel K Kulp; I-Lu Lai; En-Chi Hsu; Wei A He; David E Frankhouser; Pearlly S Yan; Xiaokui Mo; Mark Bloomston; Gregory B Lesinski; Guido Marcucci; Denis C Guttridge; Tanios Bekaii-Saab; Ching-Shih Chen
Journal:  J Natl Cancer Inst       Date:  2015-10-12       Impact factor: 13.506

9.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

10.  HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy.

Authors:  Adam W Beharry; Pooja B Sandesara; Brandon M Roberts; Leonardo F Ferreira; Sarah M Senf; Andrew R Judge
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.